Indirect Coombs Test
Großes BlutbildZuletzt geprüft: 7. April 2026. Quellenansatz: Standardkontext zur Laborinterpretation, allgemeine medizinische Referenzmaterialien sowie öffentliche Gesundheits- oder klinische Leitlinien, sofern relevant.
Was ist Indirect Coombs Test?
The indirect Coombs test, also known as the indirect antiglobulin test (IAT), detects free (unbound) antibodies circulating in the patient's serum or plasma that have the potential to bind to red blood cell (RBC) antigens. The test is performed by incubating the patient's serum with reagent red blood cells of known antigen composition. If antibodies in the serum bind to antigens on the reagent RBCs, subsequent addition of anti-human globulin (AHG) causes agglutination, indicating a positive result.
The IAT is fundamental to pretransfusion compatibility testing (crossmatching) and prenatal antibody screening. In the blood bank, it ensures that donor red blood cells are compatible with the recipient's serum before transfusion, preventing potentially fatal hemolytic transfusion reactions. In obstetrics, it screens pregnant women for clinically significant RBC alloantibodies—particularly anti-D (Rh) antibodies—that can cross the placenta and cause hemolytic disease of the fetus and newborn (HDFN). The IAT also plays a role in antibody identification panels when unexpected antibodies are detected.
Warum der Wert wichtig ist
The indirect Coombs test is critical for safe blood transfusion and prenatal care. In transfusion medicine, a positive IAT (antibody screen) means the patient has developed alloantibodies against foreign RBC antigens, likely from prior transfusion or pregnancy. These antibodies must be identified so that antigen-negative blood can be provided, preventing hemolytic transfusion reactions. In pregnancy, detection of anti-D or other clinically significant antibodies allows monitoring and intervention (anti-D immunoglobulin, intrauterine transfusion) to prevent or manage hemolytic disease of the newborn.
Normale Referenzbereiche
| Gruppe | Bereich | Einheit |
|---|---|---|
| Adults and children | Negative | (no agglutination) |
Referenzbereiche können je nach Labor variieren. Vergleichen Sie Ihre Ergebnisse immer mit den Bereichen Ihres Testlabors.
Was hohe IAT-Werte bedeuten
Häufige Ursachen
- RBC alloantibodies from prior transfusion (anti-K, anti-E, anti-Fy-a, anti-Jk-a, etc.)
- Anti-D antibodies in Rh-negative individuals sensitized by Rh-positive blood
- Naturally occurring antibodies (anti-A, anti-B in ABO system)
- Warm or cold autoantibodies reacting with screening cells
- Passively acquired antibodies (anti-D immunoglobulin, IVIG)
Mögliche Symptome
- No direct symptoms from a positive IAT
- If antibodies cause hemolysis after transfusion: fever, chills, back pain, dark urine, hypotension
- In pregnancy: fetal anemia, hydrops fetalis, neonatal jaundice (due to HDFN)
Was zu tun ist: A positive IAT triggers antibody identification using panels of reagent red blood cells with known antigen profiles. Once the antibody specificity is determined, antigen-negative compatible blood is selected for transfusion. In pregnancy, antibody titers are monitored serially—rising titers (typically critical titer ≥16 for anti-D) prompt referral for fetal surveillance including middle cerebral artery Doppler ultrasound. Rh-negative women receive anti-D immunoglobulin prophylaxis at 28 weeks and after delivery of an Rh-positive infant.
Was niedrige IAT-Werte bedeuten
Häufige Ursachen
- Normal result—no clinically significant RBC antibodies detected in serum
Mögliche Symptome
- No symptoms associated with a negative IAT
Was zu tun ist: A negative IAT means no unexpected RBC antibodies were detected, and crossmatch-compatible blood can be issued for transfusion. In pregnancy, a negative antibody screen is reassuring but should be repeated at 28 weeks gestation and after delivery. Rh-negative women with a negative screen should still receive anti-D immunoglobulin prophylaxis.
Wann wird ein IAT-Test empfohlen?
- Pretransfusion compatibility testing (type and screen)
- Prenatal antibody screening at first visit and 28 weeks
- Evaluation after suspected hemolytic transfusion reaction
- Monitoring antibody titers in alloimmunized pregnancies
- Prior to Rh immunoglobulin administration
Häufig gestellte Fragen
Verwandte Biomarker
Quellen- und Prüfungsansatz
Biomarker-Glossarseiten sind erklärende Bildungsinhalte und sollten immer zusammen mit den Referenzbereichen und Kommentaren Ihres Labors sowie Ihrer Ärztin oder Ihres Arztes interpretiert werden. Mehr zu unseren redaktionellen Standards und unserem Prüfprozess finden Sie in unserer Redaktionsrichtlinie und Prüfprozess für Inhalte.
Möchten Sie Ihre IAT-Werte analysieren lassen?
Laden Sie Ihre Laborwerte hoch und erhalten Sie sofort eine KI-gestützte Einordnung aller Biomarker.
Laborwerte hochladen →Medizinischer Hinweis: Diese Informationen dienen nur Bildungszwecken und ersetzen keine professionelle medizinische Beratung, Diagnose oder Behandlung. Referenzbereiche können zwischen Laboren variieren. Besprechen Sie die Interpretation Ihrer konkreten Testergebnisse immer mit Ihrer medizinischen Fachperson.